Cargando…
1275. Will an App-Optimized HIV Self-testing Strategy Work for South Africans? Results From a Large Cohort Study
BACKGROUND: HIV self-testing (HIVST) offers a potential for expanded test access; challenges remain in operationalizing rapid personalized linkages and referrals to care. We investigated if an app-optimized personalized HIVST strategy improved referrals, detected new infections and expedited linkage...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252956/ http://dx.doi.org/10.1093/ofid/ofy210.1108 |
_version_ | 1783373384942354432 |
---|---|
author | Pai, Nitika Pant Esmail, Ali Marathe, Gayatri Oelofse, Suzette Pretorius, Marietjie Smallwood, Megan Daher, Jana Janssen, Ricky Saha-Chaudhuri, Paramita Engel, Nora Dheda, Keertan |
author_facet | Pai, Nitika Pant Esmail, Ali Marathe, Gayatri Oelofse, Suzette Pretorius, Marietjie Smallwood, Megan Daher, Jana Janssen, Ricky Saha-Chaudhuri, Paramita Engel, Nora Dheda, Keertan |
author_sort | Pai, Nitika Pant |
collection | PubMed |
description | BACKGROUND: HIV self-testing (HIVST) offers a potential for expanded test access; challenges remain in operationalizing rapid personalized linkages and referrals to care. We investigated if an app-optimized personalized HIVST strategy improved referrals, detected new infections and expedited linkages to care and treatment. METHODS: In an ongoing cohort study (n = 2,000) based in South Africa, from November 2016 to January 2018, to participants presenting to self-test at community township based clinics, we offered a choice of the following strategies: (a) unsupervised HIVST; (b) supervised HIVST. We also observed participants opting for conventional HIV testing (ConvHT) in geographically separated clinics. We observed outcomes (i.e., linkage initiation, referrals, disease detection) and compared it between the two (HIVST vs. ConvHT) for the same duration. RESULTS: Of 2,000 participants, 1,000 participants were on HIVST, 599 (59.9%) chose unsupervised HIVST, 401 (40.1%) on supervised HIVST; compared with 1,000 participants on ConvHT. Participants in HIVST vs. ConvHT were comparable young (mean age 27.7 [SD = 9.0] vs. 29.5 [SD = 8.4]); female (64.0% vs. 74.7%); poor monthly income <3,000 RAND ($253 USD) (79.9% vs. 76.4%). With HIV ST (vs. ConvHT), many more referrals (17.4% [15.1–19.9] vs. 2.6% [1.7–3.8]; RR 6.69 [95% CI: 4.47–10.01]), and many new infections (86 (8.6% (6.9–10.5)) vs. 57 (5.7% (4.3–7.3)); Odds Ratio 1.55 [95% CI 1.1–2.2]) were noted. Break up: 45 infections in supervised HIVST 45 (52.3%); 41 infections in unsupervised HIVST (47.6%)]. Preference for HIVST was at 91.6%. With an app-optimized HIVST strategy, linkages to care were operationalized within a day in all participants (99.7% (HIVST) vs. 99.2% (ConvHT); RR 1.005 [95% CI: 0.99–1.01]); 99.8% supervised HIVST, 99.7% unsupervised HIVST. CONCLUSION: Our app-optimized HIVST strategy successfully increased test referrals, detected new infections, and operationalized linkages within a day. This innovative, patient preferred strategy holds promise for a global scale up in digitally literate populations worldwide. DISCLOSURES: All authors: No reported disclosures. |
format | Online Article Text |
id | pubmed-6252956 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-62529562018-11-28 1275. Will an App-Optimized HIV Self-testing Strategy Work for South Africans? Results From a Large Cohort Study Pai, Nitika Pant Esmail, Ali Marathe, Gayatri Oelofse, Suzette Pretorius, Marietjie Smallwood, Megan Daher, Jana Janssen, Ricky Saha-Chaudhuri, Paramita Engel, Nora Dheda, Keertan Open Forum Infect Dis Abstracts BACKGROUND: HIV self-testing (HIVST) offers a potential for expanded test access; challenges remain in operationalizing rapid personalized linkages and referrals to care. We investigated if an app-optimized personalized HIVST strategy improved referrals, detected new infections and expedited linkages to care and treatment. METHODS: In an ongoing cohort study (n = 2,000) based in South Africa, from November 2016 to January 2018, to participants presenting to self-test at community township based clinics, we offered a choice of the following strategies: (a) unsupervised HIVST; (b) supervised HIVST. We also observed participants opting for conventional HIV testing (ConvHT) in geographically separated clinics. We observed outcomes (i.e., linkage initiation, referrals, disease detection) and compared it between the two (HIVST vs. ConvHT) for the same duration. RESULTS: Of 2,000 participants, 1,000 participants were on HIVST, 599 (59.9%) chose unsupervised HIVST, 401 (40.1%) on supervised HIVST; compared with 1,000 participants on ConvHT. Participants in HIVST vs. ConvHT were comparable young (mean age 27.7 [SD = 9.0] vs. 29.5 [SD = 8.4]); female (64.0% vs. 74.7%); poor monthly income <3,000 RAND ($253 USD) (79.9% vs. 76.4%). With HIV ST (vs. ConvHT), many more referrals (17.4% [15.1–19.9] vs. 2.6% [1.7–3.8]; RR 6.69 [95% CI: 4.47–10.01]), and many new infections (86 (8.6% (6.9–10.5)) vs. 57 (5.7% (4.3–7.3)); Odds Ratio 1.55 [95% CI 1.1–2.2]) were noted. Break up: 45 infections in supervised HIVST 45 (52.3%); 41 infections in unsupervised HIVST (47.6%)]. Preference for HIVST was at 91.6%. With an app-optimized HIVST strategy, linkages to care were operationalized within a day in all participants (99.7% (HIVST) vs. 99.2% (ConvHT); RR 1.005 [95% CI: 0.99–1.01]); 99.8% supervised HIVST, 99.7% unsupervised HIVST. CONCLUSION: Our app-optimized HIVST strategy successfully increased test referrals, detected new infections, and operationalized linkages within a day. This innovative, patient preferred strategy holds promise for a global scale up in digitally literate populations worldwide. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2018-11-26 /pmc/articles/PMC6252956/ http://dx.doi.org/10.1093/ofid/ofy210.1108 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Abstracts Pai, Nitika Pant Esmail, Ali Marathe, Gayatri Oelofse, Suzette Pretorius, Marietjie Smallwood, Megan Daher, Jana Janssen, Ricky Saha-Chaudhuri, Paramita Engel, Nora Dheda, Keertan 1275. Will an App-Optimized HIV Self-testing Strategy Work for South Africans? Results From a Large Cohort Study |
title | 1275. Will an App-Optimized HIV Self-testing Strategy Work for South Africans? Results From a Large Cohort Study |
title_full | 1275. Will an App-Optimized HIV Self-testing Strategy Work for South Africans? Results From a Large Cohort Study |
title_fullStr | 1275. Will an App-Optimized HIV Self-testing Strategy Work for South Africans? Results From a Large Cohort Study |
title_full_unstemmed | 1275. Will an App-Optimized HIV Self-testing Strategy Work for South Africans? Results From a Large Cohort Study |
title_short | 1275. Will an App-Optimized HIV Self-testing Strategy Work for South Africans? Results From a Large Cohort Study |
title_sort | 1275. will an app-optimized hiv self-testing strategy work for south africans? results from a large cohort study |
topic | Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252956/ http://dx.doi.org/10.1093/ofid/ofy210.1108 |
work_keys_str_mv | AT painitikapant 1275willanappoptimizedhivselftestingstrategyworkforsouthafricansresultsfromalargecohortstudy AT esmailali 1275willanappoptimizedhivselftestingstrategyworkforsouthafricansresultsfromalargecohortstudy AT marathegayatri 1275willanappoptimizedhivselftestingstrategyworkforsouthafricansresultsfromalargecohortstudy AT oelofsesuzette 1275willanappoptimizedhivselftestingstrategyworkforsouthafricansresultsfromalargecohortstudy AT pretoriusmarietjie 1275willanappoptimizedhivselftestingstrategyworkforsouthafricansresultsfromalargecohortstudy AT smallwoodmegan 1275willanappoptimizedhivselftestingstrategyworkforsouthafricansresultsfromalargecohortstudy AT daherjana 1275willanappoptimizedhivselftestingstrategyworkforsouthafricansresultsfromalargecohortstudy AT janssenricky 1275willanappoptimizedhivselftestingstrategyworkforsouthafricansresultsfromalargecohortstudy AT sahachaudhuriparamita 1275willanappoptimizedhivselftestingstrategyworkforsouthafricansresultsfromalargecohortstudy AT engelnora 1275willanappoptimizedhivselftestingstrategyworkforsouthafricansresultsfromalargecohortstudy AT dhedakeertan 1275willanappoptimizedhivselftestingstrategyworkforsouthafricansresultsfromalargecohortstudy |